Fumimasa Kitamura

496 total citations
16 papers, 132 citations indexed

About

Fumimasa Kitamura is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Fumimasa Kitamura has authored 16 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Fumimasa Kitamura's work include Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Fumimasa Kitamura is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Fumimasa Kitamura collaborates with scholars based in Japan, United States and Singapore. Fumimasa Kitamura's co-authors include Norio Uemura, Hiromitsu Hayashi, Katsunori Imai, Yo‐ichi Yamashita, Rumi Itoyama, Hideo Baba, Yosuke Nakao, Hirohisa Okabe, Toshihiko Yusa and Shigeki Nakagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgical Oncology and World Journal of Surgery.

In The Last Decade

Fumimasa Kitamura

15 papers receiving 131 citations

Peers

Fumimasa Kitamura
Fumimasa Kitamura
Citations per year, relative to Fumimasa Kitamura Fumimasa Kitamura (= 1×) peers Silvia Chiellino

Countries citing papers authored by Fumimasa Kitamura

Since Specialization
Citations

This map shows the geographic impact of Fumimasa Kitamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumimasa Kitamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumimasa Kitamura more than expected).

Fields of papers citing papers by Fumimasa Kitamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumimasa Kitamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumimasa Kitamura. The network helps show where Fumimasa Kitamura may publish in the future.

Co-authorship network of co-authors of Fumimasa Kitamura

This figure shows the co-authorship network connecting the top 25 collaborators of Fumimasa Kitamura. A scholar is included among the top collaborators of Fumimasa Kitamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumimasa Kitamura. Fumimasa Kitamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kitamura, Fumimasa, et al.. (2024). Screening for Deep Vein Thrombosis Using D-dimer Levels Based on Surgical Patients’ Characteristics. Cureus. 16(12). e75565–e75565.
2.
Fu, Lingfeng, Atsuko Yonemura, Noriko Yasuda‐Yoshihara, et al.. (2022). Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer. Gastric Cancer. 25(3). 542–557. 20 indexed citations
3.
Zhang, Jun, Lingfeng Fu, Noriko Yasuda‐Yoshihara, et al.. (2022). IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment. Gastric Cancer. 26(2). 187–202. 15 indexed citations
4.
Hayashi, Hiromitsu, Norio Uemura, Yoko Ogata, et al.. (2022). Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma. Translational Oncology. 26. 101533–101533. 12 indexed citations
5.
Nakao, Yosuke, Hiromitsu Hayashi, Yo‐ichi Yamashita, et al.. (2022). Risk factors for lymph node metastasis in patients with pancreatic neuroendocrine neoplasms. World Journal of Clinical Oncology. 13(6). 520–528. 2 indexed citations
6.
Kitamura, Fumimasa, Tatsunori Miyata, Norio Uemura, et al.. (2021). Proteomic Analysis of Malignant Ascites From Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. 41(6). 2895–2900. 4 indexed citations
7.
El‐mezayen, Hatem A., Kensuke Yamamura, Toshihiko Yusa, et al.. (2021). MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma. Annals of Surgical Oncology. 28(12). 7973–7982. 11 indexed citations
8.
Mima, Kosuke, Hiromitsu Hayashi, Shigeki Nakagawa, et al.. (2021). Frailty is associated with poor prognosis after resection for pancreatic cancer. International Journal of Clinical Oncology. 26(10). 1938–1946. 22 indexed citations
9.
Itoyama, Rumi, Hirohisa Okabe, Yo‐ichi Yamashita, et al.. (2021). Intraoperative bile culture helps choosing antibiotics in pancreaticoduodenectomy: Mechanistic profiling study of complex rink between bacterobilia and postoperative complications. Journal of Hepato-Biliary-Pancreatic Sciences. 28(12). 1107–1114. 7 indexed citations
10.
Hayashi, Hiromitsu, Norio Uemura, Zhao Liu, et al.. (2020). Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma. In Vivo. 34(5). 2845–2850. 5 indexed citations
11.
Ogawa, Daisuke, Hiromitsu Hayashi, Fumimasa Kitamura, et al.. (2020). Multiple cholangiocarcinomas in the intrahepatic and extrahepatic biliary tree due to dichloromethane exposure: a case report. SHILAP Revista de lepidopterología. 6(1). 79–79. 4 indexed citations
12.
Yamashita, Yo‐ichi, Hiromitsu Hayashi, Katsunori Imai, et al.. (2019). Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis. World Journal of Surgery. 43(11). 2894–2901. 12 indexed citations
13.
Imai, Katsunori, Yo‐ichi Yamashita, Yosuke Nakao, et al.. (2018). Is disease progression a contraindication for the strategy of portal vein embolization followed by hepatectomy for hepatocellular carcinoma?. Surgery. 165(4). 696–702. 9 indexed citations
14.
Kitamura, Fumimasa, et al.. (2018). Primary extramedullary plasmacytoma of the sigmoid colon with perforation: a case report. SHILAP Revista de lepidopterología. 4(1). 28–28. 6 indexed citations
15.
Doi, Koichi, et al.. (2018). [A Case of Study Stable Disease after Hepatic Arterial Infusion Chemotherapy in a Patient with Systemic Chemotherapy-Resistant Liver Metastases of Colon Cancer].. PubMed. 45(1). 181–183. 1 indexed citations
16.
Hirota, Masahiko, Hiroki Sugita, Shinobu Honda, et al.. (2017). No-Touch Total Mesopancreas Excision for Pancreatic Head Cancer. JOP, journal of the pancreas. 18(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026